21. November 2009 03:53
Renowned B.C. kinesiologist and heart disease researcher Dr. Scott Lear is the inaugural recipient of the Pfizer/Heart and Stroke Foundation Chair in Cardiovascular Disease Prevention Research at St. Paul's Hospital, established in partnership with Simon Fraser University (SFU).
[More]
21. November 2009 00:32
Pfizer today announced that the U.S. Food and Drug Administration (FDA) has approved Geodon® (ziprasidone HCI) Capsules for maintenance treatment of bipolar I disorder as an adjunct to lithium or valproate in adults. The approval is based on clinical data demonstrating that Geodon is an effective and generally well-tolerated adjunctive treatment for long-term symptom control in patients with bipolar disorder.
[More]
e509995b-1b4e-4e92-b105-966405d5524b|1|5.0
Posted in: Medical Condition News | Pharmaceutical News
Tags: Antipsychotic, Arrhythmia, Bipolar Disorder, Blood Pressure, Dementia, Diabetes, Hyperglycemia, Mental Health, Pfizer, Pharmacology, Psychiatry, Psychosis, Schizophrenia
20. November 2009 09:18
Pfizer announced today that the U.S. Food and Drug Administration (FDA) has approved Revatio® (sildenafil) Injection, an intravenous formulation of Revatio. Revatio is the only FDA-approved phosphodiesterase-5 (PDE5) inhibitor available in both tablet and intravenous formulations.
[More]
85b72941-1acc-4d4b-b579-2fd76594d425|0|.0
Posted in: Medical Condition News | Pharmaceutical News
Tags: Blood Pressure, Efavirenz, Erectile Dysfunction, Exercise, Headache, Heart Failure, Impotence, Low Blood Pressure, Nevirapine, Pfizer, Pulmonary Arterial Hypertension, Ritonavir, Stroke, Veno-Occlusive Disease, Vitamin K, Warfarin
20. November 2009 08:37
Ligand Pharmaceuticals Incorporated today announced that data from a preclinical study on its selective androgen receptor modulator (SARM) LGD-4033 was featured in a poster presentation at the 62nd Annual Meeting of the Gerontology Society of America in Atlanta. LGD-4033 exhibited desirable in vivo efficacy on skeletal muscle and bone measurements in animal models of male hypogonadism and postmenopausal osteoporosis.
[More]
f23b18ab-0bd0-4d21-ad99-95fb9aaafa02|0|.0
Posted in: Medical Science News | Medical Condition News
Tags: Anemia, Arthritis, Asthma, Biotechnology, Bone, Bone Mineral Density, Cancer, Cell, Gene Expression, Gerontology, Osteoporosis, Pfizer, Psoriasis, Rheumatoid Arthritis, Sexual Dysfunction, Testosterone
20. November 2009 04:42
Research and Markets has announced the addition of the "CNS Therapeutics - A World Market Review" report to their offering.
[More]
20. November 2009 04:04
Research and Markets has announced the addition of the "Pharmaceutical Contract Manufacturing - Global Market Trends" report to their offering.
[More]
20. November 2009 02:21
Leading patient advocacy organizations announced today that they are teaming up for the first time on an initiative to encourage patients with lung cancer to take charge of their diagnosis and learn about clinical trials, which are an important part of treatment innovation.
[More]
20. November 2009 01:37
Research and Markets (http://www.researchandmarkets.com/research/4b82d8/cancer_therapies) has announced the addition of the "Cancer Therapies - Global Market Opportunities" report to their offering.
[More]
d1ec933e-6b16-4c92-bf1f-1cae23f4af72|0|.0
Posted in: Device / Technology News
Tags: Abraxane, Antibody, Avastin, Bone, Bone Marrow, Cancer, Cell, Chemotherapy, Colorectal Cancer, Diabetes, Drug Delivery, Gemzar, Genetics, Genomics, Hormonal Therapy, Immunization, Immunotherapy, Pfizer, Proteomics, Radiation Therapy, Smoking, Stem Cell, Tarceva, Taxotere, Xeloda
20. November 2009 01:06
Research and Markets (http://www.researchandmarkets.com/research/f6bf5e/hepatitis_c_virus) has announced the addition of the "Hepatitis C Virus And Therapeutics - A Global Update of Market Trends & Opportunities" report to their offering.
[More]
20. November 2009 00:20
Research and Markets (http://www.researchandmarkets.com/research/27e3e3/australia_pharmace) has announced the addition of the "Australia Pharmaceuticals and Healthcare Report Q1 2010" report to their offering.
[More]
20. November 2009 00:16
A team led by scientists at The Scripps Research Institute have discovered a direct link between insulin-a hormone long associated with metabolism and metabolic disorders such as diabetes-and core body temperature. While much research has been conducted on insulin since its discovery in the 1920s, this is the first time the hormone has been connected to the fundamental process of temperature regulation.
[More]
8ab6b755-b25b-4761-a40b-16eba752d9c0|0|.0
Posted in: Medical Research News | Medical Condition News
Tags: Brain, Brown Fat, Cell, Cellular Biology, Diabetes, Hypothermia, Immunology, Insulin, Metabolism, Obesity, Pfizer, Sleep, Vaccine, Weight Loss
20. November 2009 00:10
Research and Markets (http://www.researchandmarkets.com/research/e7b41e/kenya_pharmaceutic) has announced the addition of the "Kenya Pharmaceuticals and Healthcare Report Q1 2010" report to their offering.
[More]
19. November 2009 23:57
Research and Markets (http://www.researchandmarkets.com/research/5f3158/alzheimers_and_pa) has announced the addition of the "Alzheimer's and Parkinson's Diseases - A Global Update of Market Trends & Opportunities" report to their offering.
[More]
19. November 2009 22:41
Ligand Pharmaceuticals Incorporated announced today that it has received $2 million in milestone payments from N. V. Organon, a subsidiary of Merck & Co., Inc., stemming from its research collaboration that is due to expire at the end of December.
[More]
19. November 2009 22:17
Pfizer and the Drugs for Neglected Diseases Initiative (DNDi) on Wednesday announced plans to team up in an effort to identify new drug candidates for the treatment of three tropical diseases, the Associated Press/Business Week reports. The scientists will test the efficacy of Pfizer drug candidates against sleeping sickness, visceral leishmaniasis, and Chagas disease.
[More] 
Subscribe